Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on October 14, 2026

3 hours ago

CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026

Indeterminate GlobeNewswire

3 hours ago

Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

Indeterminate GlobeNewswire

3 hours ago

iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch

Indeterminate GlobeNewswire

3 hours ago

Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study

Indeterminate GlobeNewswire

3 hours ago

Bluesight Launches Prism Assistant in PrivacyPro, Bringing AI-Powered Investigations to Patient Privacy Teams

Indeterminate GlobeNewswire

3 hours ago

Adagene to Participate in H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference

Indeterminate GlobeNewswire

3 hours ago

Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026

Indeterminate GlobeNewswire

3 hours ago

Rhea’s Factory Partners with Niagara Bottling on Industrial Validation of Enzymatic PET Recycling Through U.S. Department of Energy Program

Indeterminate GlobeNewswire

3 hours ago

TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity

Indeterminate GlobeNewswire

3 hours ago

Purespring Therapeutics to present new data on pipeline progress in Alport Syndrome at the American Society of Nephrology (ASN) Kidney Week 2026

Indeterminate GlobeNewswire

4 hours ago

Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome

Indeterminate GlobeNewswire

4 hours ago

BreathiZen Introduces BreathiZen Spray With Mullein Leaf Extract, Ginger Root Extract, Bromelain, and Organic Lemon Extract 60 ml

Indeterminate GlobeNewswire

4 hours ago

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026

Indeterminate GlobeNewswire

4 hours ago

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Indeterminate GlobeNewswire

4 hours ago

Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

4 hours ago

Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome

Indeterminate GlobeNewswire

4 hours ago

Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45

Indeterminate GlobeNewswire

4 hours ago

Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise

Indeterminate GlobeNewswire

4 hours ago

Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients

Indeterminate GlobeNewswire